Members-only Site   |   Print Page   |   Contact Us   |   Sign In   |   Register
Press Releases
Share |

Press Releases



IACP Applauds the Leadership of Congressmen Griffith and Cuellar in Introducing Bill HR 2871, 6.13.17


Coalition Encourages State Boards to Ensure DQSA Implemented as Congress Intended, 1.20.16


IACP Files Formal Comments on Proposed FDA Memorandum of Understanding, 7.21.15


IACP Supports Legislation in Louisiana to Protect Consumers, 5.12.15


ACHC Partners with the International Academy of Compounding Pharmacists (IACP), 4.15.15


IACP Adopts Position on Compounding of Lethal Injection Drugs, 3.24.15


Access to Compounded Medication Coverage for 140,000 TRICARE Military Heroes and Families Clears Major Hurdle, 1.20.15


Broad Provider and Pharmacy Coalition Urges Congress to Fix Drug Quality and Security Act, December 10, 2014


Seeking Greater Clarity and Direction from FDA, IACP Supports Congressional Funding Restriction, 06.10.14


IACP Offering Webinar on Stark Law and False Claims Act, 03.19.14


IACP Announces Nominations for FDA Pharmacy Compounding Advisory Committee, 3.14.14


IACP Seeks FDA Approval of Bulk Drug Substances List for Compounding Pharmacists, 3.5.14


Cynthia E. Blankenship, Esq., Joins IACP as VP of Government Affairs, 11.11.13


Compromise Compounding Bill will not Improve Quality, Safety, 9.27.13


IACP Position on the Compounding Clarity Act of 2013, 09.20.13


IACP Testifies Before Senate, 05.09.13


IACP Responds to 60 Minutes Broadcast, 03.10.13


IACP Issues State Guidance


IACP: FDA Authority is Clear, Direct, And Certain


Statement From IACP EVP/CEO David Miller, R.Ph. Regarding Congressman Markey's Bill


Background and Facts on Compounding Pharmacies from IACP


IACP Responds to Meningitis Outbreak Release


IACP Responds to FDA's Makena® 17-P Update




Association Management Software Powered by YourMembership  ::  Legal